Torrent Pharmaceuticals Ltd
The live share price of Torrent Pharmaceuticals Ltd (TORNTPHARM) as on 28 Mar 10:14am is ₹2,600.6 from NSE/BSE.
TORNTPHARM NSE
₹2,600.6 ▲1.1% (28.2)
As on Mar 28, 2024 03:44 PM IST
Key Metrics
PE Ratio
58.27
PB Ratio
14.05
Dividend Yield
0.86%
Sector PB
5.88
Sector PE
51.33
Sector Div Yld
0.57%
Dividend Yield
Dividend per share for the most recent financial year divided by the close price
About
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.
The following charts display the financial performance of the Torrent Pharmaceuticals Ltd (TORNTPHARM) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.
Furthermore, under the Peers section, you can find stocks that are similar to Torrent Pharmaceuticals Ltd (TORNTPHARM), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.
✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.
A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.
All smallcases are created and managed by SEBI-registered investment experts.
To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.
Financials
Income Statement
(INR) | Y/Y Change | |
Revenue | 9,665 Cr | +11.04% |
Operating Expense | 873 Cr | -29.79% |
Net Income | 1,245 Cr | +60.22% |
Net Profit Margin | 12.88% | +44.23% |
Earning Per Share | 36 | +60.21% |
EBITDA | 2,887 Cr | +34.72% |
Balance sheet
(INR) | Y/Y Change | |
Cash & short-term Inv | 727 Cr | +23.86% |
Total Assets | 14,609 Cr | +13.2% |
Total Liabilities | 8,411 Cr | +20.98% |
Total Equity | 6,198 Cr | +4.12% |
Shares Outstanding | 33.84 Cr | -0.01% |
Price to Book | 8.39 | +5.91% |
Return on Assets | 9.05% | +57.12% |
Return on Capital | 35.18 Cr | +41.4% |
Cash Flows
(INR) | Y/Y Change | |
Net Income | 1,245 Cr | +60.22% |
Cash from Operations | 2,368 Cr | +31.34% |
Cash from Investing | -2,335 Cr | +1090.9% |
Cash from Financing | 77 Cr | -104.34% |
Net Change in Cash | 110 Cr | -163.23% |
Free Cash Flow | 1,794 Cr | +12.11% |
Peers
SUNPHARMA
Sun Pharmaceutical Industries Ltd
PE Ratio
43.22
1Y Return
▲63.11%
CIPLA
Cipla Ltd
PE Ratio
31.86
1Y Return
▲68.29%
DRREDDY
Dr Reddy's Laboratories Ltd
PE Ratio
19.25
1Y Return
▲36.03%
ZYDUSLIFE
Zydus Lifesciences Ltd
PE Ratio
33.83
1Y Return
▲107.81%
Latest News
Torrent Pharma shares hit 52-week high on successful inspection by USFDA
3 weeks ago on Moneycontrol
Change since news ▼-INF%
The share price gained 80 percent in last one-year.
3 weeks ago on Bloomberg Quint
Change since news ▼-INF%
Domestic formulations sector, secular growth stories
Diabetes, BP drugs to cost less as NPPA fixes retail prices of 69 formulations
4 weeks ago on Moneycontrol
Change since news ▼-INF%
Various drugs manufactured by listed players like Sun Pharmaceuticals, Alkem Laboratories, Cipla Ltd, Mankind Pharma, Lupin Ltda and Torrent Pharma are included in the list.
Torrent Pharma Q3 Results Review - Margin Improvement Continues: Prabhudas Lilladher
2 months ago on Bloomberg Quint
Change since news ▼-INF%
Key markets like India, Brazil and Germany reported double digit growth.
Torrent Pharma Q3 Results Review - Strong Performance Across Branded Markets: Nirmal Bang
2 months ago on Bloomberg Quint
Change since news ▼-INF%
Domestic revenue grew by 12% YoY to Rs 14.15 billion.
Torrent Pharma Q3 Results Review - India, Latin America Drive Earnings: Motilal Oswal
2 months ago on Bloomberg Quint
Change since news ▼-INF%
Profitability remains on uptrend
Trade setup for Monday: 15 things to know before opening bell
2 months ago on Moneycontrol
Change since news ▼-INF%
A long build-up was seen in 69 stocks, which included Hindustan Copper, Alkem Laboratories, Cummins India, Torrent Pharmaceuticals, and Atul.
Torrent Pharma Q3 PAT Jumps 52% To Rs 443 Crore
2 months ago on Bloomberg Quint
Change since news ▼-INF%
The drug firm had reported a net profit of Rs 292 crore in the October-December period of the last fiscal.
Tata Motors, IndiGo, Torrent Pharma Q3 Results Today — Earnings Estimates
2 months ago on Bloomberg Quint
Change since news ▼-INF%
Here are the earnings estimates of major companies that are scheduled to announce their results on Friday.
FAQs on Torrent Pharmaceuticals Ltd
How to buy Torrent Pharmaceuticals Ltd stocks?
You can easily buy the stocks/shares of Torrent Pharmaceuticals Ltd (TORNTPHARM) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.
What is the Share Price of Torrent Pharmaceuticals Ltd?
The stock price of Torrent Pharmaceuticals Ltd as on 28 Mar 2024 is ₹2,600.6
What is the 52-week High and Low of Torrent Pharmaceuticals Ltd?
The 52-week high and low of Torrent Pharmaceuticals Ltd (TORNTPHARM) is ₹2,744 and ₹1,513.55.
What is the PE and PB ratio of Torrent Pharmaceuticals Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Torrent Pharmaceuticals Ltd are 58.27 and 14.05 respectively.
What are the peers or stocks similar to Torrent Pharmaceuticals Ltd?
The peers or stocks similar to Torrent Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.
Which sector does Torrent Pharmaceuticals Ltd belong to?
Torrent Pharmaceuticals Ltd (TORNTPHARM) belongs to the Pharmaceuticals sector.
What is the Market Cap of Torrent Pharmaceuticals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Torrent Pharmaceuticals Ltd (TORNTPHARM) is ₹87,061 Cr as of 28 Mar 2024
Can't decide whether or not to buy Torrent Pharmaceuticals Ltd stocks? ⭐️
Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.